Clinical Trials Logo

Burpenorphine clinical trials

View clinical trials related to Burpenorphine.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT03221309 Active, not recruiting - HCV Clinical Trials

Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior

ANCHOR
Start date: May 1, 2017
Phase:
Study type: Observational

This is an open label, non-randomized, observational pilot study to evaluate a model of care for treatment of hepatitis C in people with ongoing injection drug use. Participants will be treated with direct-acting antivirals (DAA) as per standard of care and will concomittantly be offered pre-exposure prophylaxis for HIV prevention and buprenorphine for treatment of opioid use disorder when clinically indicated.